The new profile of drug-resistant tuberculosis in Russia : a global and local perspective : summary of a joint workshop by the Institute of Medicine and the Russian Academy of Medical Science /

Mostrar otras versiones (1)

An estimated 2 billion people, one third of the global population, are infected with Mycobacterium tuberculosis, the bacterium that causes tuberculosis. Spread through the air, this infectious disease killed 1.7 million in 2009, and is the leading killer of people with HIV. Tuberculosis (TB) is also...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autores Corporativos: Institute of Medicine (U.S.). Forum on Drug Discovery, Development, and Translation, Rossiĭskai͡a akademii͡a medit͡sinskikh nauk
Otros Autores: Olson, Steve, 1956-, English, Rebecca A., Claiborne, Anne B.
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Washington, D.C. : National Academies Press, ©2011.
Colección:Online access: NCBI NCBI Bookshelf.
Temas:
Multidrug-resistant tuberculosis > Congresses.
Multidrug-resistant tuberculosis > Russia > Congresses.
Mycobacterium tuberculosis > Congresses.
Antitubercular agents > Congresses.
Multidrug-resistant tuberculosis.
Tuberculosis.
Antitubercular agents.
Tuberculosis, Multidrug-Resistant
Tuberculosis, Pulmonary
Antibiotics, Antitubercular
Tuberculosis
Antitubercular Agents
Tuberculose multirésistante > Congrès.
Tuberculose multirésistante > Russie > Congrès.
Mycobacterium tuberculosis > Congrès.
Antituberculeux > Congrès.
Tuberculose multirésistante.
Tuberculose.
Antituberculeux.
MEDICAL > Forensic Medicine.
MEDICAL > Preventive Medicine.
MEDICAL > Public Health.
Antitubercular agents
Multidrug-resistant tuberculosis
Mycobacterium tuberculosis
Russia
Congress
proceedings (reports)
Conference papers and proceedings
Conference papers and proceedings.
Actes de congrès.
Acceso en línea:Texto completo
Tabla de Contenidos:
  • Introduction
  • A global perspective on drug-resistant tuberculosis
  • Drug-resistant tuberculosis in the Russian Federation
  • Transmission and infection control of drug-resistant TB
  • Diagnosis of drug-resistant TB
  • Treatment of drug-resistant TB
  • TB and drug-resistant TB in vulnerable populations
  • The second-line drug supply chain
  • The development of new TB diagnostics and drugs
  • Convergence of science and policy to create a call for action.

Ejemplares similares